Grant: Banting Postdoctoral Fellowship Program
Direct Payment
$140,000.00
Elucidating the Role of Skeletal Muscle SIRT1/PGC-1a Metabolic Axis in Modulating Angiogenesis: Can Vascular Aging be Reversed?
EF 2011-12
Résumé
Over the last 50 years, the proportion of the Canadian population over 65 y has nearly tripled, with a concomitant rise in the incidence of aging-associated ischemic diseases that continuously threatens to overwhelm our healthcare system. Investigating mechanisms that may prevent and reverse ischemic diseases to enhance the quality of life and reduce mortality in our elderly population has become a public health priority. Ischemic tissues can create new blood vessels (angiogenesis), in an attempt to recruit more oxygen and nutrients. That response, however, declines profoundly with age resulting in functional impairment, disability, and even amputation in the elderly. What instigates the ischemic disease process remains unclear. We have recently identified, in skeletal muscle, a new genetic program for making new blood vessels that is driven by a protein: PGC-1alpha. PGC-1alpha is a powerful physiological regulator of metabolism uniquely poised as a potential target for aging-associated diseases. The SIRT1 lifespan regulator positively modulates PGC-1alpha, and treatment with naturally occurring SIRT1-activating compounds leads to PGC-1alpha activation in skeletal muscle. Hence, PGC-1alpha provides a novel and powerful link between metabolism, vascular function, and pathways known to be critical in the aging process. Together, the data support the hypothesis that declines in the activity of the SIRT1/PGC-1alpha pathway underlie the profound age-associated loss of angiogenic capacity in skeletal muscle, and that reversal of this process will improve the tolerance to ischemia in the elderly. We aim to critically test this hypothesis using both cell culture systems and genetically modified mouse models. The proposed studies will provide new insight into vascular balance in the elderly, and identify novel therapeutic targets for ischemic diseases of all guises.
Programme
Banting Postdoctoral Fellowship Program
Bénéficiaire
Emplacement
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
247352
Name
Safdar Syed A
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
Elucidating the Role of Skeletal Muscle SIRT1/PGC-1a Metabolic Axis in Modulating Angiogenesis: Can Vascular Aging be Reversed?
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Adenoviral Transfection/Cell Culture; Aging; Angiogenesis; Elisa; Ischemia Disease; Pgc-1a/Sirt1 Metabolism; Quantitative Real-Time Rt-Pcr; Skeletal Muscle - Hind Limb Ischemia Model; Transgenic Mouse Models; Western Blot
Abstract
Over the last 50 years, the proportion of the Canadian population over 65 y has nearly tripled, with a concomitant rise in the incidence of aging-associated ischemic diseases that continuously threatens to overwhelm our healthcare system. Investigating mechanisms that may prevent and reverse ischemic diseases to enhance the quality of life and reduce mortality in our elderly population has become a public health priority. Ischemic tissues can create new blood vessels (angiogenesis), in an attempt to recruit more oxygen and nutrients. That response, however, declines profoundly with age resulting in functional impairment, disability, and even amputation in the elderly. What instigates the ischemic disease process remains unclear. We have recently identified, in skeletal muscle, a new genetic program for making new blood vessels that is driven by a protein: PGC-1alpha. PGC-1alpha is a powerful physiological regulator of metabolism uniquely poised as a potential target for aging-associated diseases. The SIRT1 lifespan regulator positively modulates PGC-1alpha, and treatment with naturally occurring SIRT1-activating compounds leads to PGC-1alpha activation in skeletal muscle. Hence, PGC-1alpha provides a novel and powerful link between metabolism, vascular function, and pathways known to be critical in the aging process. Together, the data support the hypothesis that declines in the activity of the SIRT1/PGC-1alpha pathway underlie the profound age-associated loss of angiogenic capacity in skeletal muscle, and that reversal of this process will improve the tolerance to ischemia in the elderly. We aim to critically test this hypothesis using both cell culture systems and genetically modified mouse models. The proposed studies will provide new insight into vascular balance in the elderly, and identify novel therapeutic targets for ischemic diseases of all guises.
Competitiondate
201111
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Safdar, Syed A
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~